| Literature DB >> 31802441 |
Shobna J Bhatia1, Govind K Makharia2, Philip Abraham3, Naresh Bhat4, Ajay Kumar5, D Nageshwar Reddy6, Uday C Ghoshal7, Vineet Ahuja2, G Venkat Rao6, Krishnadas Devadas8, Amit K Dutta9, Abhinav Jain10, Saurabh Kedia2, Rohit Dama6, Rakesh Kalapala6, Jose Filipe Alvares11, Sunil Dadhich12, Vinod Kumar Dixit13, Mahesh Kumar Goenka14, B D Goswami15, Sanjeev K Issar16, Venkatakrishnan Leelakrishnan17, Mohandas K Mallath18, Philip Mathew19, Praveen Mathew20, Subhashchandra Nandwani21, Cannanore Ganesh Pai22, Lorance Peter23, A V Siva Prasad24, Devinder Singh25, Jaswinder Singh Sodhi26, Randhir Sud27, Jayanthi Venkataraman28, Vandana Midha29, Amol Bapaye30, Usha Dutta31, Ajay K Jain32, Rakesh Kochhar31, Amarender S Puri33, Shivram Prasad Singh34, Lalit Shimpi35, Ajit Sood29, Rajkumar T Wadhwa36.
Abstract
The Indian Society of Gastroenterology developed this evidence-based practice guideline for management of gastroesophageal reflux disease (GERD) in adults. A modified Delphi process was used to develop this consensus containing 58 statements, which were generated by electronic voting iteration as well as face-to-face meeting and review of the supporting literature primarily from India. These statements include 10 on epidemiology, 8 on clinical presentation, 10 on investigations, 23 on treatment (including medical, endoscopic, and surgical modalities), and 7 on complications of GERD. When the proportion of those who voted either to accept completely or with minor reservation was 80% or higher, the statement was regarded as accepted. The prevalence of GERD in India ranges from 7.6% to 30%, being < 10% in most population studies, and higher in cohort studies. The dietary factors associated with GERD include use of spices and non-vegetarian food. Helicobacter pylori is thought to have a negative relation with GERD; H. pylori negative patients have higher grade of symptoms of GERD and esophagitis. Less than 10% of GERD patients in India have erosive esophagitis. In patients with occasional or mild symptoms, antacids and histamine H2 receptor blockers (H2RAs) may be used, and proton pump inhibitors (PPI) should be used in patients with frequent or severe symptoms. Prokinetics have limited proven role in management of GERD.Entities:
Keywords: Barrett’s esophagus; Esophageal manometry; Esophageal pH monitoring; Proton pump inhibitors
Mesh:
Substances:
Year: 2019 PMID: 31802441 DOI: 10.1007/s12664-019-00979-y
Source DB: PubMed Journal: Indian J Gastroenterol ISSN: 0254-8860